Jeffrey A. Meckler
Director · Travere Therapeutics, Inc.
IndividualSelling only11 10b5-1 trades
- 2024
- Sep 11, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey A. Meckler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eric M. Dube - $41.35M in TVTX purchases and sales in the last 12 months
- Peter Heerma - $18.77M in TVTX purchases and sales in the last 12 months
- William E. Rote - $14.02M in TVTX purchases and sales in the last 12 months
- Elizabeth E. Reed - $7.02M in TVTX purchases and sales in the last 12 months
- Christopher R. Cline - $4.64M in TVTX purchases and sales in the last 12 months
- Jula Inrig - $4.53M in TVTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey A. Meckler?
Jeffrey A. Meckler is a corporate insider, tracked as Director of Travere Therapeutics, Inc. (TVTX). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jeffrey A. Meckler submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jeffrey A. Meckler been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($1.71M) across all tracked filings.
